Research Recommendations Following the Discovery of Pain Sensitizing IgG Autoantibodies in Fibromyalgia Syndrome.

"the data sets generated and/or analyzed during the current study are available in the figshare repository [doi: 10 6084/m9 figshare 12602186 (will become activated following acceptance for publication)] conception: a g design of the work: acquisition of data: a g d a c b n b c bk s b r b r e c d c d d r d h f m g z h s i e k j l g m f h m c a m r m s p n s e s c s c sn a w g w e d analysis and interpretation of data: a g e d drafted the work: a g e d all authors have reviewed and approved the manuscript. availability of data and materials. the data sets generated and/or analyzed during the current study are available in the figshare"

" : Conflicts of interest: E.C. has received research grants, honoraria and served as member of advisory boards and speaker bureaus of Abbvie, BioCancer, Biocon, Biogen, Bristol Myer Squibbs, Chugai Pharma, Eli Lilly, Gilead, Janssen, Merck Serono, Novartis, Pfizer, Regeneron, Roche, Sanofi, and UCB. J.L. and E.S. are employees and shareholder of Eli Lilly and Company; SRI is supported by the Wellcome Trust (104079/Z/14/Z), the UCB-Oxford University Alliance, BMA Research Grants- Vera Down grant (2013) and Margaret Temple (2017), Epilepsy Research UK (P1201), the Fulbright UK-US commission (MS-Society research award) and by the NIHR Oxford Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health). S.R.I. is a coapplicant and receives royalties on patent application WO/210/046716 (U.K. patent no., PCT/GB2009/051441) entitled ‘Neurological Autoimmune Disorders’. The patent has been licensed to Euroimmun AG for the development of assays for LGI1 and other VGKC-complex antibodies. All other authors declare that they have no potential conflicts.: Funding sources: The project was funded through an educational grant and received administrative support from Versus Arthritis, a UK research charity focussed on improving lives of people living with musculoskeletal conditions https://www.versusarthritis.org/ (total £10,000). Administrative support was provided by the Pain Relief Foundation, Liverpool, a research charity dedicated to supporting research into the causes and treatment of chronic pain https://painrelieffoundation.org.uk/. Z.H. was supported by Hungarian Brain Research Program (20017-1.2.1-NKP-2017-00002, NAP2.0) and EFOP-3.6.2-16-2017-00008."

" : Conflicts of interest: E.C. has received research grants, honoraria and served as member of advisory boards and speaker bureaus of Abbvie, BioCancer, Biocon, Biogen, Bristol Myer Squibbs, Chugai Pharma, Eli Lilly, Gilead, Janssen, Merck Serono, Novartis, Pfizer, Regeneron, Roche, Sanofi, and UCB. J.L. and E.S. are employees and shareholder of Eli Lilly and Company; SRI is supported by the Wellcome Trust (104079/Z/14/Z), the UCB-Oxford University Alliance, BMA Research Grants- Vera Down grant (2013) and Margaret Temple (2017), Epilepsy Research UK (P1201), the Fulbright UK-US commission (MS-Society research award) and by the NIHR Oxford Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health). S.R.I. is a coapplicant and receives royalties on patent application WO/210/046716 (U.K. patent no., PCT/GB2009/051441) entitled ‘Neurological Autoimmune Disorders’. The patent has been licensed to Euroimmun AG for the development of assays for LGI1 and other VGKC-complex antibodies. All other authors declare that they have no potential conflicts.: Funding sources: The project was funded through an educational grant and received administrative support from Versus Arthritis, a UK research charity focussed on improving lives of people living with musculoskeletal conditions https://www.versusarthritis.org/ (total £10,000). Administrative support was provided by the Pain Relief Foundation, Liverpool, a research charity dedicated to supporting research into the causes and treatment of chronic pain https://painrelieffoundation.org.uk/. Z.H. was supported by Hungarian Brain Research Program (20017-1.2.1-NKP-2017-00002, NAP2.0) and EFOP-3.6.2-16-2017-00008."